Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.05 USD | -1.87% | +7.74% | -23.91% |
09/05 | Transcript : Bluebird bio, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
06/05 | Bluebird Bio, Inc. Announces Completion of First Cell Collection for LYFGENIA Gene Therapy | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.91% | 21Cr | |
+8.29% | 11TCr | |
+10.21% | 11TCr | |
+0.41% | 2.23TCr | |
-11.90% | 2.22TCr | |
-5.99% | 1.94TCr | |
-37.36% | 1.79TCr | |
-5.17% | 1.72TCr | |
+7.70% | 1.43TCr | |
+37.65% | 1.25TCr |
- Stock Market
- Equities
- BLUE Stock
- News bluebird bio, Inc.
- Barclays Upgrades bluebird bio to Overweight From Equalweight, Adjusts Price Target to $8 From $7